Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16066 | 608 | 41.7 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
464 | 15237 | MICROALBUMINURIA//GLOMERULAR FILTRATION RATE//CYSTATIN C |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OBESITY RELATED GLOMERULOPATHY | Author keyword | 9 | 67% | 1% | 8 |
2 | SENSOR BIOANALYT SCI | Address | 3 | 42% | 1% | 5 |
3 | HYPERFILTRATION NEPHROPATHY | Author keyword | 2 | 67% | 0% | 2 |
4 | GLOMERULOMEGALY | Author keyword | 1 | 25% | 1% | 5 |
5 | E GFR | Author keyword | 1 | 50% | 0% | 2 |
6 | 3 4 DIHYDROXYACETOPHENONE | Author keyword | 1 | 40% | 0% | 2 |
7 | NEPHRONOL | Address | 1 | 40% | 0% | 2 |
8 | NEPHRONOL UROL | Address | 1 | 40% | 0% | 2 |
9 | MED F RECANATI | Address | 1 | 33% | 0% | 2 |
10 | ATHEROSCLEROSIS REFERENCE | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MASSIVE OBESITY | 23 | 47% | 6% | 36 |
2 | OBESITY RELATED GLOMERULOPATHY | 10 | 47% | 3% | 16 |
3 | EXTREMELY OBESE PATIENTS | 8 | 75% | 1% | 6 |
4 | INITIATED METABOLIC SYNDROME | 3 | 43% | 1% | 6 |
5 | NEPHROTIC PROTEINURIA | 3 | 50% | 1% | 4 |
6 | RENAL HYPERFILTRATION | 1 | 38% | 0% | 3 |
7 | PEDIATRIC NEPHROLOGY PATIENTS | 1 | 50% | 0% | 2 |
8 | RENAL LIPID METABOLISM | 1 | 15% | 1% | 6 |
9 | SALT SENSITIVE PATIENTS | 1 | 16% | 1% | 4 |
10 | ALLEVIATING DIABETIC COMPLICATIONS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis | 2011 | 99 | 41 | 41% |
Metabolic syndrome and chronic kidney disease | 2013 | 29 | 32 | 44% |
Effects of weight loss on renal function in obese CKD patients: a systematic review | 2013 | 12 | 52 | 56% |
Obesity and Kidney Disease: Potential Mechanisms | 2013 | 21 | 76 | 34% |
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease | 2014 | 7 | 95 | 28% |
Association between obesity and kidney disease: A systematic review and meta-analysis | 2008 | 133 | 70 | 31% |
Structural Renal Changes in Obesity and Diabetes | 2013 | 18 | 74 | 35% |
Glomerular hyperfiltration: definitions, mechanisms and clinical implications | 2012 | 57 | 87 | 18% |
Is there an obesity-metabolic syndrome related glomerulopathy? | 2011 | 20 | 45 | 64% |
Obesity and chronic kidney disease | 2011 | 23 | 45 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SENSOR BIOANALYT SCI | 3 | 42% | 0.8% | 5 |
2 | NEPHRONOL | 1 | 40% | 0.3% | 2 |
3 | NEPHRONOL UROL | 1 | 40% | 0.3% | 2 |
4 | MED F RECANATI | 1 | 33% | 0.3% | 2 |
5 | ATHEROSCLEROSIS REFERENCE | 1 | 50% | 0.2% | 1 |
6 | BOTUCATU MED OOL | 1 | 50% | 0.2% | 1 |
7 | CHRONIC DIS PREVENT HLTH PROMOT | 1 | 50% | 0.2% | 1 |
8 | CLEVELAND CLIN LERNER MED CWRU | 1 | 50% | 0.2% | 1 |
9 | DIABET AUDIT DIABET INFORMAT SERV | 1 | 50% | 0.2% | 1 |
10 | DIALYSIS TRANSPLANTAT UNIT REGGIO CA RIA | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000265535 | CLIN EXCELLENCE METAB VASC DIS//OBESITY DEGREE//POST TRANSPLANT WEIGHT GAIN |
2 | 0.0000187815 | LATE REFERRAL//NEPHROLOGY REFERRAL//CHRONIC KIDNEY DISEASE CKD |
3 | 0.0000141036 | MICROALBUMINURIA//ALBUMINURIA//URINARY ALBUMIN EXCRETION |
4 | 0.0000128551 | GLYCATED ALBUMIN//CHRONIC KIDNEY DISEASE DETECTION//CHRONIC KIDNEY DISEASE STAGES |
5 | 0.0000127170 | SPECIALIZED HYPERTENS GENET//HYPERTENS GENET SPECIALIZED//BIOMED IL 236 |
6 | 0.0000121523 | IDIOPATHIC NODULAR GLOMERULOSCLEROSIS//NODULAR GLOMERULOSCLEROSIS//KIMMELSTIEL WILSON NODULES |
7 | 0.0000109563 | DIABETIC GLOMERULOPATHY//NON DIABETIC RENAL DISEASE//STRUCTURAL FUNCTIONAL RELATIONSHIPS |
8 | 0.0000099773 | CYSTATIN C//GLOMERULAR FILTRATION RATE//COCKCROFT GAULT |
9 | 0.0000093308 | NEPHROL S 151//ANALBUMINEMIA//IMPAIRED EXERCISE CAPACITY |
10 | 0.0000091903 | PROTEIN ENERGY WASTING//JOURNAL OF RENAL NUTRITION//INTRADIALYTIC PARENTERAL NUTRITION |